**Pfizer to Cut Jobs in Switzerland Amid Cost-Cutting Strategy**
Pfizer, the US-based pharmaceutical giant, is planning to reduce its workforce in Switzerland significantly as part of a multi-year cost reduction initiative. According to a report from Bloomberg on December 10, 2025, the company aims to decrease its Swiss employee count from approximately 300 to around 70 by the end of 2025, resulting in the layoff of over 200 staff members.
This decision follows a broader reassessment of Pfizer’s Swiss operations, which has seen a downgrade within the company’s structure. Earlier this month, Sabine Bruckner, who previously led Pfizer’s operations in Switzerland, was replaced by Rea Lal, who now oversees a reduced scope of responsibilities. Bruckner has since transitioned to a new role within the company.
Pfizer’s job cuts are part of a larger strategy to achieve $7 billion in savings by 2027, as the company seeks to streamline its operations and reduce complexity. A spokesperson for Pfizer indicated that the company is focused on “realigning” its resources to enhance efficiency.
The layoffs come at a time when Pfizer’s Swiss business is facing challenges, particularly as new corporate tax regulations have made the region less attractive for some multinational companies. This trend is not isolated, as other pharmaceutical firms, including Novartis AG, have also announced job cuts in Switzerland, with Novartis planning to eliminate up to 550 positions due to automation efforts.
As of the latest trading session, Pfizer’s stock saw a slight increase, trading at $25.48, up from $25.33 at the previous close.
In summary, Pfizer’s significant job cuts in Switzerland reflect ongoing efforts to adapt to changing market conditions and streamline operations in pursuit of long-term growth.
**FAQ**
**What is the reason behind Pfizer’s job cuts in Switzerland?**
Pfizer is cutting jobs in Switzerland as part of a multi-year cost reduction program aimed at saving $7 billion by 2027, driven by a need to streamline operations and respond to changing market conditions.
